RENEO PHARMACEUTICALS INC's ticker is RPHM and the CUSIP is 75974E103. A total of 40 filers reported holding RENEO PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,043 | -78.6% | 531 | -81.6% | 0.00% | – |
| Q2 2023 | $18,906 | -24.4% | 2,882 | -61.5% | 0.00% | – |
| Q3 2022 | $25,000 | +19.0% | 7,495 | -4.9% | 0.00% | – |
| Q2 2022 | $21,000 | +950.0% | 7,879 | +936.7% | 0.00% | – |
| Q1 2022 | $2,000 | -90.9% | 760 | -71.1% | 0.00% | – |
| Q4 2021 | $22,000 | +144.4% | 2,629 | +127.4% | 0.00% | – |
| Q3 2021 | $9,000 | +200.0% | 1,156 | +285.3% | 0.00% | – |
| Q2 2021 | $3,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RiverVest Venture Management LLC | 2,409,220 | $8,071,000 | 9.37% |
| Abingworth LLP | 2,073,957 | $6,948,000 | 2.38% |
| Aisling Capital Management LP | 886,075 | $2,968,000 | 1.97% |
| NEA Management Company, LLC | 4,786,921 | $16,036,000 | 0.80% |
| Novo Holdings A/S | 3,430,377 | $11,492,000 | 0.55% |
| Ikarian Capital, LLC | 155,819 | $521,000 | 0.10% |
| Rock Springs Capital Management LP | 1,143,185 | $3,830,000 | 0.10% |
| Ergoteles LLC | 37,640 | $126,000 | 0.00% |
| MAI Capital Management | 63,210 | $212,000 | 0.00% |
| RBF Capital, LLC | 14,536 | $49,000 | 0.00% |